Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5619-5629
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5619
Table 3 Characteristics of patients with pancreatic cancer according to the international classification of diseases, 10th revision edition
ParametersN (%)C250C251C252C253C254C257C259
Number of patients1846234 (12.7)272 (3.9)104 (5.6)5 (0.3)2 (0.1)1 (0.1)1428 (77.4)
Age at diagnosis65.22 ± 11.97164.72 ± 10.1463.39 ± 10.4865.43 ± 11.3265.20 ± 11.0870.50 ± 4.9545.00 ± 0.0065.39 ± 12.35
Gender (male: Female)1116:730150:8445:2752:521:42:01:0865:563
Diagnostic criteria
Definite910 (49.3)164 (70.1)34 (47.2)45 (43.3)2 (40.0)2 (100.0)1 (100.0)662 (46.4)
Possible936 (50.7)70 (29.9)38 (52.8)59 (56.7)3 (60.0)0 (0.0)0 (0.0)766 (53.6)
Methods of pathologic diagnosis (n = 910)
ERCP or endoscopy163 (17.9)34 (20.7)2 (5.9)8 (17.8)0 (0.0)0 (0.0)0 (0.0)119 (18.0)
EUS-FNA or percutaneous biopsy30 (3.3)4 (2.4)0 (0.0)2 (4.4)0 (0.0)0 (0.0)0 (0.0)26 (3.9)
Surgery717 (78.8)126 (76.8)32 (94.1)35 (77.8)2 (100.0)2 (100.0)1 (100.0)517 (78.1)
CA19-9 > 100 U/L
Yes684 (37.1)95 (40.6)29 (40.3)44 (42.3)1 (20.0)0 (0.0)0 (0.0)515 (36.1)
No514 (27.8)63 (26.9)24 (33.3)23 (22.1)1 (20.0)1 (50.0)0 (0.0)402 (28.2)
Missing648 (35.1)76 (32.5)19 (26.4)37 (35.6)3 (60.0)1 (50.0)1 (100.0)511 (35.8)